Cargando…

Non-neutralizing antibodies and vaccine-induced protection

Detalles Bibliográficos
Autores principales:	Demberg, Thorsten, Florese, Ruth H, Gomez-Roman, V Raul, Larsen, Kay, Van Rompay, Koen KA, Marthas, Marta L, Venzon, David, Kalyanaraman, VS, Pal, Ranajit, Barnett, Susan W, Cafaro, Aurelio, Ensoli, Barbara, Robert-Guroff, Marjiorie
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716934/ http://dx.doi.org/10.1186/1742-4690-3-S1-S26

Ejemplares similares

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)

Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals
por: Greenier, Jennifer L, et al.
Publicado: (2005)

Effects of the Deletion of Early Region 4 (E4) Open Reading Frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on Virus-Host Cell Interaction, Transgene Expression, and Immunogenicity of Replicating Adenovirus HIV Vaccine Vectors
por: Thomas, Michael A., et al.
Publicado: (2013)

Controlling the HIV/AIDS epidemic: current status and global challenges
por: Demberg, Thorsten, et al.
Publicado: (2012)

Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11
por: Van Rompay, Koen KA, et al.
Publicado: (2006)

Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques
por: Vargas-Inchaustegui, Diego A., et al.
Publicado: (2016)

Challenges in HIV Vaccine Research for Treatment and Prevention
por: Ensoli, Barbara, et al.
Publicado: (2014)

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge
por: Campbell, Christopher T., et al.
Publicado: (2013)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
por: Jensen, K, et al.
Publicado: (2012)

CD4-Induced epitopes in HIV infection
por: DeVico, Anthony, et al.
Publicado: (2006)

Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
por: Van Rompay, Koen KA, et al.
Publicado: (2007)

Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector
por: Thomas, Michael A., et al.
Publicado: (2016)

P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
por: Valentin, A, et al.
Publicado: (2009)

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
por: Cafaro, Aurelio, et al.
Publicado: (2019)

Limited range correlations, when modulated by firing rate, can substantially improve neural population coding
por: Zylberberg, Joel, et al.
Publicado: (2015)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Design clues from functional constraints and broadly neutralizing antibodies
por: Zhou, Tongqing, et al.
Publicado: (2006)

Epigenetics & modern phenotypes: the biological nonsense of sub-talar neutral
por: Quinn, Greg
Publicado: (2010)

Neutral contrast MRI for the detection of peripheral arterial wall calcifications
por: Edelman, Robert R, et al.
Publicado: (2014)

HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology
por: Cafaro, Aurelio, et al.
Publicado: (2016)

The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
por: Nicoli, Francesco, et al.
Publicado: (2020)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
por: Franchini, G, et al.
Publicado: (2012)

Non-genomic thyroid hormone signaling through NO/cGMP/PKGII
por: Kalyanaraman, Hema, et al.
Publicado: (2013)

Neutralization of Interferon-gamma is efficacious in a mouse model of HLH secondary to chronic inflammation
por: Prencipe, G, et al.
Publicado: (2015)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
por: Ensoli, Barbara, et al.
Publicado: (2016)

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
por: Ensoli, Barbara, et al.
Publicado: (2021)

An evaluation of coronary artery plaque burden in asymptomatic type 2 diabetics using dual-source CT coronary angiography
por: Patel, M, et al.
Publicado: (2012)

Towards a multi-antigen multi-stage malaria vaccine
por: Hill, Adrian VS, et al.
Publicado: (2014)

Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
por: Clumeck, Nathan, et al.
Publicado: (2006)

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
por: Kovacs, JM, et al.
Publicado: (2012)

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
por: Zolla-Pazner, Susan, et al.
Publicado: (2006)

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
por: Nicoli, Francesco, et al.
Publicado: (2013)

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
por: Moody, M, et al.
Publicado: (2012)

Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin and DC SIGN positive compartments that are accessible to neutralizing antibodies
por: Johnson, Erica L, et al.
Publicado: (2014)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
por: Kapulu, Melissa C, et al.
Publicado: (2010)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fr3qkptg4lrl87auf7grd5d5mv